CRISPR’s 20-Minute Coronavirus Test Receives Funding From NIH

Mammoth Biosciences has received funding from the NIH’s RADx programme to develop a CRISPR-based coronavirus test.

Read the full post on Forbes - Healthcare

Andrew Williams, Contributor